89bio Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for liver and cardio-metabolic diseases. With its proprietary platform technology, 89bio aims to address unmet medical needs and improve outcomes for patients worldwide.
Notification